Literature DB >> 28084557

Microstructural and Radioluminescence Characteristics of Nd3+ Doped Columbite-Type SrNb2O6 Phosphor.

Mete Kaan Ekmekçi1, Mustafa İlhan2, Arzu Ege3, Mehmet Ayvacıklı3.   

Abstract

Undoped and different concentration Nd3+ doped SrNb2O6 powders with columbite structure were synthesized by molten salt process using a mixture of strontium nitrate and niobium (V) oxide and NaCl-KCl salt mixture as a flux under relatively low calcining temperature. X-ray diffraction analysis results indicated that SrNb2O6 phases found to be orthorhombic columbite single phase for undoped, 0.5 and 3 mol% Nd3+ doping concentrations. Phase composition of the powders was examined by SEM-EDS analyses. Radioluminescence properties of Nd3+ doped samples from UV to near-IR spectral region were studied. The emissions increased with the doping concentration of up to 3 mol%, and then decreased due to concentration quenching effect. There is a sharp emission peak around 880 nm associated with 4F5/2 → 4I9/2 transition in the Nd3+ ion between 300 and 1100 nm. The broad emission band intensity was observed from 400 to 650 nm where the peak intensities increased by increasing Nd3+ doping concentration. All the measurements were taken under the room temperature.

Entities:  

Keywords:  Molten salt synthesis; Radioluminescence; Strontium metaniobate

Year:  2017        PMID: 28084557     DOI: 10.1007/s10895-017-2032-3

Source DB:  PubMed          Journal:  J Fluoresc        ISSN: 1053-0509            Impact factor:   2.217


  1 in total

1.  Visible to infrared low temperature luminescence of Er(3+), Nd(3+) and Sm(3+) in CaSnO3 phosphors.

Authors:  V Orsi Gordo; Y Tuncer Arslanli; A Canimoglu; M Ayvacikli; Y Galvão Gobato; M Henini; N Can
Journal:  Appl Radiat Isot       Date:  2015-02-21       Impact factor: 1.513

  1 in total
  1 in total

1.  Judd-Ofelt parameters and X-ray irradiation results of MNb2O6:Eu3+ (M = Sr, Cd, Ni) phosphors synthesized via a molten salt method.

Authors:  Mustafa İlhan; Mete Kaan Ekmekçi; İlker Çetin Keskin
Journal:  RSC Adv       Date:  2021-03-10       Impact factor: 3.361

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.